Financhill
Sell
39

ARGX Quote, Financials, Valuation and Earnings

Last price:
$775.67
Seasonality move :
6.39%
Day range:
$758.99 - $801.20
52-week range:
$510.06 - $934.62
Dividend yield:
0%
P/E ratio:
42.59x
P/S ratio:
16.45x
P/B ratio:
6.40x
Volume:
830K
Avg. volume:
374.1K
1-year change:
23.84%
Market cap:
$47.7B
Revenue:
$2.2B
EPS (TTM):
$21.30

Analysts' Opinion

  • Consensus Rating
    argenx SE has received a consensus rating of Buy. The company's average rating is a Buy based on 15 Buy ratings, 1 Hold rating, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $1,031.68, argenx SE has an estimated upside of 33.72% from its current price of $771.53.
  • Price Target Downside
    According to analysts, the lowest downside price target is $639.88 representing 17.06% downside risk from its current price of $771.53.

Fair Value

  • According to the consensus of 16 analysts, argenx SE has 33.72% upside to fair value with a price target of $1,031.68 per share.

ARGX vs. S&P 500

  • Over the past 5 trading days, argenx SE has underperformed the S&P 500 by -8.93% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • argenx SE does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • argenx SE has grown year-over-year revenues for 12 quarters straight. In the most recent quarter argenx SE reported revenues of $948M.

Earnings Growth

  • argenx SE has grown year-over-year earnings for 0 quarters straight. In the most recent quarter argenx SE reported earnings per share of $3.74.
Enterprise value:
47.7B
EV / Invested capital:
--
Price / LTM sales:
16.45x
EV / EBIT:
120.84x
EV / Revenue:
15.57x
PEG ratio (5yr expected):
--
EV / Free cash flow:
106.58x
Price / Operating cash flow:
112.61x
Enterprise value / EBITDA:
114.39x
Gross Profit (TTM):
$2.7B
Return On Assets:
21.14%
Net Income Margin (TTM):
41.88%
Return On Equity:
28.06%
Return On Invested Capital:
24.23%
Operating Margin:
21.5%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-06-30 2024-06-30 2025-06-30 2024-06-30 2025-06-30
Income Statement
Revenue $803.2M $1.6B $3.1B $474.9M $948M
Gross Profit $631.6M $1.3B $2.7B $422.5M $837.2M
Operating Income -$565M -$399.4M $394.5M -$43.9M $203.8M
EBITDA -$459M -$287.3M $416.8M -$14.4M $288M
Diluted EPS -$7.17 -$3.50 $19.67 $0.49 $3.74
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Balance Sheet
Current Assets $2.9B $2.9B $2.7B $4.3B $5.8B
Total Assets $3.2B $3.2B $3.2B $4.8B $7.2B
Current Liabilities $244M $264.6M $317.8M $499.6M $1B
Total Liabilities $261.1M $279M $335.7M $534.3M $1.1B
Total Equity $3B $3B $2.9B $4.3B $6.1B
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2023-06-30 2024-06-30 2025-06-30 2024-06-30 2025-06-30
Cash Flow Statement
Cash Flow Operations -$619.1M -$145.5M $542.7M -$124.7M $361.8M
Cash From Investing $258.8M -$846.1M -$276.5M -$513.8M $62.3M
Cash From Financing $102.5M $1.3B $313.3M $40.1M $73.5M
Free Cash Flow -$723.4M -$211.2M $447.4M -$147M $312.8M
ARGX
Sector
Market Cap
$47.7B
$25.8M
Price % of 52-Week High
82.55%
50.24%
Dividend Yield
0%
0%
Shareholder Yield
-1.02%
-1.64%
1-Year Price Total Return
23.84%
-18.88%
Beta (5-Year)
0.374
0.496
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $829.45
200-day SMA
Buy
Level $738.03
Bollinger Bands (100)
Sell
Level 807.31 - 883.69
Chaikin Money Flow
Buy
Level 3.1M
20-day SMA
Sell
Level $832.26
Relative Strength Index (RSI14)
Sell
Level 33.76
ADX Line
Sell
Level 11.27
Williams %R
Buy
Level -86.6368
50-day SMA
Sell
Level $830.07
MACD (12, 26)
Sell
Level -5.19
25-day Aroon Oscillator
Sell
Level -84
On Balance Volume
Neutral
Level 22.4M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (32.6158)
Buy
CA Score (Annual)
Level (1.4453)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-4.6111)
Buy
Piotroski F Score (Annual)
Level (6)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (7)

Revenue Forecast

Earnings per Share Forecast

Company Profile

argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.

Stock Forecast FAQ

In the current month, ARGX has received 15 Buy ratings 1 Hold ratings, and 0 Sell ratings. The ARGX average analyst price target in the past 3 months is $1,031.68.

  • Where Will argenx SE Stock Be In 1 Year?

    According to analysts, the consensus estimate is that argenx SE share price will rise to $1,031.68 per share over the next 12 months.

  • What Do Analysts Say About argenx SE?

    Analysts are divided on their view about argenx SE share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that argenx SE is a Sell and believe this share price will drop from its current level to $639.88.

  • What Is argenx SE's Price Target?

    The price target for argenx SE over the next 1-year time period is forecast to be $1,031.68 according to 16 Wall Street analysts, 15 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.

  • Is ARGX A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for argenx SE is a Buy. 15 of 16 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of ARGX?

    You can purchase shares of argenx SE via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase argenx SE shares.

  • What Is The argenx SE Share Price Today?

    argenx SE was last trading at $775.67 per share. This represents the most recent stock quote for argenx SE. Yesterday, argenx SE closed at $771.53 per share.

  • How To Buy argenx SE Stock Online?

    In order to purchase argenx SE stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Sell
50
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 38x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Sell
37
Is GOOGL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Buy
59
SEZL alert for Feb 27

Sezzle, Inc. [SEZL] is down 14.29% over the past day.

Buy
83
GCT alert for Feb 27

GigaCloud Technology, Inc. [GCT] is down 7.51% over the past day.

Buy
62
LMAT alert for Feb 27

LeMaitre Vascular, Inc. [LMAT] is down 5.73% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock